Recall of multiple batches of the product NEGAZOLE 250MG Tablet
2026-08-09
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer NEGAZOLE 250MG Tablet METRONIDAZOLE 0501268860 06056,06764,09307 United Arab Emirates
التصنيف
ملف
التاريخ
2026-08-03
اسم المستحضر
NEGAZOLE 250MG Tablet
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
SFDA has issued a recall of multiple batches of NEGAZOLE 250 mg Tablets due to the presence of black spots on the tablets surface due to abrasion of the tablet film coating, resulting in the affected batches failing to meet the approved specifications., which may compromise the product's quality and safety.
التوصيات
For healthcare professionals: Stop dispensing the batch immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batch, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.